Mimedx (MDXG) Other Non-Current Liabilities (2011 - 2026)

Mimedx (MDXG) has 16 years of Other Non-Current Liabilities data on file, last reported at $5.1 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities fell 31.98% year-over-year to $5.1 million; the trailing twelve-month figure through Mar 2026 stood at $5.1 million (down 31.98% YoY), and the FY2025 full-year result was $5.4 million, down 27.24% from the prior year.
• Other Non-Current Liabilities fell to $5.1 million in Q1 2026, from $5.4 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $7.5 million in Q1 2025 to a low of $2.2 million in Q4 2023.
• A 5-year average of $4.8 million and a median of $4.8 million in 2022 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities slumped 53.43% in 2023 and surged 232.12% in 2024, its largest moves.
• Tracing MDXG's Other Non-Current Liabilities over 5 years: stood at $4.8 million in 2022, then tumbled by 53.43% to $2.2 million in 2023, then surged by 232.12% to $7.4 million in 2024, then declined by 27.24% to $5.4 million in 2025, then slipped by 5.14% to $5.1 million in 2026.
• Business Quant data shows MDXG's Other Non-Current Liabilities at $5.1 million in Q1 2026, $5.4 million in Q4 2025, and $5.5 million in Q3 2025.